Position in GNLX
as of Dec 31, 2025
· filed Feb 6, 2026
Position Value
$946,521
-$13,918 QoQ
Shares Held
217,092
-5.1% QoQ
Ownership
0.484%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025Global Retirement Partners, LLC holds $11,158,495 across 152 Biotechnology names. GNLX ranks #3 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,345 | $1,969,849 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,499 | $1,157,033 | |
| 3 | GNLX |
GENELUX Corp
This page
|
217,092 | $946,521 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,856 | $738,038 | |
| 5 | INSM |
INSMED Inc
|
3,838 | $667,965 | |
| 6 | ARGX |
Argenx SE
|
730 | $613,893 | |
| 7 | EXEL |
Exelixis, Inc.
|
10,527 | $461,398 | |
| 8 | INCY |
Incyte Corp
|
4,406 | $435,180 |
All Filings in GNLX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $946,521 | 217,092 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $960,439 | 228,676 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $656,300 | 228,676 | Shares | Sole | 2025-08-12 | |
| 2024-12-31 | $11,800 | 5,000 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $11,850 | 5,000 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $9,750 | 5,000 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $32,150 | 5,000 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $35,025 | 2,500 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $61,225 | 2,500 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $81,800 | 2,500 | Shares | Sole | 2023-07-20 | |
| No filing history on record for this holder in this stock. | ||||||